United States
Germany
Japan
United Kingdom
China
ALS2 (tGFP-tagged) - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
Products
ALS2 (tGFP-tagged) - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
ALS2 (Myc-DDK-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
ALS2 (Myc-DDK-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
ALS2 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Lenti-ORF clone of ALS2 (Myc-DDK-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2, Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti-ORF clone of ALS2 (mGFP-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Purified recombinant protein of Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2, full length, with N-terminal HIS tag, expressed in E. coli, 50ug
| Tag | N-His |
| Expression Host | E. coli |
ALS2 CRISPRa kit - CRISPR gene activation of human alsin Rho guanine nucleotide exchange factor ALS2
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
ALS2 (untagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
ALS2 (untagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
ALS2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
ALS2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
